Ascendis Pharma A (ASND) Non-cash Items (2012 - 2026)

Ascendis Pharma A has disclosed Non-cash Items across 15 years of filings, most recently posting -$9.5 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at -$9.5 million, up 48.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.5 million (up 48.69% YoY), and the FY2025 annual result was -$143.8 million, up 55.12% from the prior year.
• Non-cash Items came in at -$9.5 million for Q1 2026 at Ascendis Pharma A, up from -$143.8 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of -$9.5 million in Q1 2026 to a low of -$520.6 million in Q4 2022.
• The 5-year median for Non-cash Items is -$170.4 million (2024), against an average of -$223.5 million.
• Across the five-year window, Non-cash Items plunged 49.32% in 2022 and surged 94.35% in 2025, its largest moves.
• Ascendis Pharma A's Non-cash Items stood at -$520.6 million in 2022, then advanced by 4.05% to -$499.5 million in 2023, then jumped by 35.85% to -$320.4 million in 2024, then surged by 55.12% to -$143.8 million in 2025, then jumped by 93.43% to -$9.5 million in 2026.
• The last three Non-cash Items figures came in at -$9.5 million (Q1 2026), -$143.8 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.